Sopharma Trading AD (BUL:SO5) entered into an agreement to acquire SCS Franchise Group for approximately BGN 25 million on March 19, 2020. The integration of SOpharmacy and SCS Franchise will strengthen the market presence of both chains to ensure an even stronger response to the growing needs of Bulgarian patients for quality healthcare services. The acquisition is subject to the prior approval by the Commission for Protection of Competition and closing is conditional upon authorization by general meeting of shareholder of Sopharma Trading. As of July 23, 2020, Bulgarian Commission for Protection of Competition approved the deal. As on September 25, 2020, shareholders of Sopharma Trading AD approved the transaction. Sopharma Trading AD (BUL:SO5) completed the acquisition of SCS Franchise Group on October 1, 2020. Post-closing, pharmacies acquired under SCS Franchise Group from the Ceiba and Sanita chains, which will adopt the physical appearance of the SOpharmacy brand.